These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 19360863)

  • 1. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventable deaths, never events, and comparative effectiveness: it is time for US cardiologist to switch to transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):416-7. PubMed ID: 19681112
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
    Eichhöfer J; Horlick E; Ivanov J; Seidelin PH; Ross JR; Ing D; Daly P; Mackie K; Ridley B; Schwartz L; Barolet A; Dzavík V
    Am Heart J; 2008 Nov; 156(5):864-70. PubMed ID: 19061699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Now, I am proud to be a Radialist.
    Saito S
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):418-9. PubMed ID: 19681114
    [No Abstract]   [Full Text] [Related]  

  • 5. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
    Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
    J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.
    Siudak Z; Zawislak B; Dziewierz A; Rakowski T; Jakala J; Bartus S; Noworolnik B; Zasada W; Dubiel JS; Dudek D
    Coron Artery Dis; 2010 Aug; 21(5):292-7. PubMed ID: 20453640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for major bleeding and for minor bleeding after percutaneous coronary intervention in 634 consecutive patients with acute coronary syndromes.
    Pierre-Louis B; Aronow WS; Yoon JH; Ahn C; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Ther; 2010; 17(4):e74-7. PubMed ID: 19455020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction--the RADIAL-AMI pilot randomized trial.
    Cantor WJ; Puley G; Natarajan MK; Dzavik V; Madan M; Fry A; Kim HH; Velianou JL; Pirani N; Strauss BH; Chisholm RJ
    Am Heart J; 2005 Sep; 150(3):543-9. PubMed ID: 16169338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.
    Iqbal Z; Cohen M; Pollack C; Goldstein P; Zeymer U; Huber K; Barthelemy O; Cayla G; Aout M; Vicaut E; Montalescot G;
    Am J Cardiol; 2013 Jun; 111(12):1727-33. PubMed ID: 23528027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate results of percutaneous coronary intervention for unprotected left main coronary artery stenoses: transradial versus transfemoral approach.
    Hsueh SK; Hsieh YK; Wu CJ; Fang CY; Youssef AA; Chen CJ; Chen SM; Yang CH; Yip HK; Chen MC; Fu M; Cheng CI
    Chang Gung Med J; 2008; 31(2):190-200. PubMed ID: 18567420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.
    Bertrand OF; Larose E; Rodés-Cabau J; Gleeton O; Taillon I; Roy L; Poirier P; Costerousse O; Larochellière RD
    Am Heart J; 2009 Jan; 157(1):164-9. PubMed ID: 19081414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
    Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction.
    Yan ZX; Zhou YJ; Zhao YX; Liu YY; Shi DM; Guo YH; Cheng WJ
    Chin Med J (Engl); 2008 May; 121(9):782-6. PubMed ID: 18701040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of door-to-balloon times for primary PCI using transradial versus transfemoral approach.
    Pancholy S; Patel T; Sanghvi K; Thomas M; Patel T
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):991-5. PubMed ID: 20517957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence.
    Lee MS; Wolfe M; Stone GW
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1149-52. PubMed ID: 24262614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy).
    Sciahbasi A; Pristipino C; Ambrosio G; Sperduti I; Scabbia EV; Greco C; Ricci R; Ferraiolo G; Di Clemente D; Giombolini C; Lioy E; Tubaro M
    Am J Cardiol; 2009 Mar; 103(6):796-800. PubMed ID: 19268734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.